Liaoning Cheng Da Biotechnology

Liaoning Cheng Da Biotechnology Co Ltd is a prominent biotech company specialising in the research and development, manufacturing, sales, and marketing of vaccines both in China and international markets. The company has established a strong reputation with its major products including a chromatographically purified rabies vaccine for human use derived from Vero cells, which has achieved sales of 400 million doses across more than 30 countries without any reported immunisation failures. Additionally, the firm produces an inactivated Japanese encephalitis vaccine for human use, also from Vero cells, representing a new generation of "Green" vaccines that are free of preservatives, adjuvants, and antibiotics. Liaoning Cheng Da has various vaccines in the pipeline that are expected to reach the market in the near future.

Services include:
- Anatomical Therapeutic Chemical (ATC) Classification
- APIs (Active Pharmaceutical Ingredients)
- Vaccine development and manufacturing
- Regulatory compliance support
- Marketing and distribution services

Liaoning Cheng Da Biotechnology is dedicated to advancing public health through innovative vaccine solutions and comprehensive pharmaceutical services. For more information, please visit cdbio.cn.